cancer. Neoplasms
Conditions
Interventions
Intervention 1: diclofenac jel .1 geram.1 our once. Intervention 2: emla cream .topical 1 geram.1ouronce. Intervention 3: vitamin(A+D).1 geram.1 our once.
Treatment - Drugs
Placebo
diclofenac jel .1 geram.1 our once
emla cream .topical 1 geram.1ouronce
vitamin(A+D).1 geram.1 our once
Sponsors
Vice chancellor for research Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
12 Years to 99 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Inclination to participate in research; Having verbal, subjective, vision ability; At present there is no acute psychiatric disorder; There is no history of favism, congenital idiopathic hemoglobin, liver disease, skin allergy, skin dermatitis; no treatment with sulfonamides, nitrates Phenobarbital, non-diabetes, non-addiction, non-use of housing in the last 24 hours. Exit criteria: The wound of the port's location during the intervention; Infection and secretion at the port site during the intervention; Failure to follow the first action.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Emlacream. Timepoint: During the intervention. Method of measurement: Geram.;Diclofenac gel. Timepoint: During the intervention. Method of measurement: Geram.;Vitamin(A+D). Timepoint: During the intervention. Method of measurement: Geram. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sex. Timepoint: During the intervention. Method of measurement: Patient case.;Duration under chemotherapy. Timepoint: During the intervention. Method of measurement: Day.;Age. Timepoint: During the intervention. Method of measurement: Years.;Severity of pain. Timepoint: During the intervention. Method of measurement: Vas.;Duration of port usage. Timepoint: During the intervention. Method of measurement: Day. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShima Mohammadinejad
Zahedan Nursing Midwifery Faculty
Outcome results
None listed